Global Periodontal Market Size

Periodontal Market Analysis

The Global Periodontal Market size is estimated at USD 1.96 billion in 2024, and is expected to reach USD 2.62 billion by 2029, growing at a CAGR of 5.91% during the forecast period (2024-2029).

The number of hospital visits related to dental care has decreased since the COVID-19 pandemic outbreak. The main causes of fewer visits to dental clinics were the fear of contracting the virus, postponing dental surgery procedures, and online consultation. Moreover. Following the initial wave of the COVID-19 pandemic, dental practices in some countries appeared to be returning to normal. According to the study titled "The Impact of the COVID-19 Pandemic on Dentistry and Dental Education: A Narrative Review" International Journal of Environmental Research and Public Health in February 2022, after the initial quarantine, about 80% of Italian dentists resumed their regular practice. Due to the virus's long-term evolution, there were some regional variations. For instance, the percentage of dental offices that reopened varied from 36% in the United Kingdom to 47% in Palestine, while it reached 99% in Italy and the United States. Thus, such incidents hampered the market's growth in the initial phase of the outbreak, however, the market is anticipated to gain traction over the coming years.

The growth of the global periodontal market is due to the increasing geriatric population across the world. Medical and dental tourism is experiencing growth in developing markets, which is also one of the prime factors responsible for market growth. For instance, as per a March 2022 update by the World Health Organization (WHO), it is estimated that oral diseases affect nearly 3.5 billion people worldwide, and severe periodontal (gum) disease, which may result in tooth loss, is also common, with almost 10% of the global population affected. Also, as per the United Nation's World Ageing Highlight of 2020, 727 million people were living around the world at the age of 65 and more. This number is expected to reach 1.5 billion by 2050, which complements the growth of the cosmetics dentistry market. As per the report, the share of the geriatric population in the world population was 9.3% in 2020, and by 2050, it is expected to reach 16% of the total world population. Thus, the increasing geriatric population is expected to drive the growth of the market for periodontal treatment as these groups are more prone to dental diseases, thereby driving the demand for the personal market.

Major corporations are creating potential drug candidates to enhance the treatment of periodontal disease which is expected to boost market growth. For instance, in March 2021, Amyndas Pharmaceuticals reported encouraging top-line Phase II results. For its randomised, placebo-controlled clinical trial evaluating AMY-101 in 39 patients with periodontal inflammation and gingivitis.

However, in developing countries, ignorance of personal hygiene is negatively affecting the growth of the periodontal market.